Solutions to support better heart health
Cardiovascular disease is the leading cause of death in the United States. Cardiovascular conditions such as coronary heart disease, diabetes, stroke, congestive heart failure, and more claim someone’s life every 38 seconds. Implementing a behaviorally-based intervention creates positive outcomes for patients with these conditions, impacting both the lifestyle of the patient and their medical condition. GoMo Health Concierge Care solutions work to support better heart health.
GoMo Health Concierge Care is right for your organization if your needs include:
Increased reimbursements such as CMS or MACRA
Reduced emergency department visits and readmissions
Improved transition support
Elimination of gaps in care
Improved patient satisfaction audits such as HEDIS, STAR, and HCAHPS
Scaled clinical service delivery
Increased joy in practice
American Heart Association cardiac disease management content
In collaboration with The American Heart Association’s Center for Health Technology and Innovation, GoMo Health Concierge Care integrates and dynamically presents American Heart Association care plans, assessments, and content to patients enrolled in our cardiovascular disease management programs. Personalized content is delivered to patients at the most appropriate points in the healthcare journeys through use of GoMo Health solutions including Care Messages (SMS or Email), learning management systems, and more.
A new approach to delivering precision healthcare
Cognitive and behavioral principles of engagement are used to activate patients and members through BehavioralRx®, the science of precision health.
See our Cardiology solutions in action
How can sleep patterns affect cardiovascular disease?
According to the American Heart Association, lack of sleep can drastically affect an individual’s cardiovascular system, including such adverse effects as high blood pressure and coronary artery disease. Learn how sleep is essential to healthy living, especially for people with cardiovascular disease, in our latest White Paper.